Predict your next investment

Kactus Biosystems company logo
HEALTHCARE | Biotechnology
kactusbio.com

See what CB Insights has to offer

Founded Year

2018

Stage

Series A - II | Alive

Total Raised

$11.18M

About Kactus Biosystems

Kactus Biosystems is a biotechnology company focused on delivering protein and antibody products and technologies for immune therapy and IVD customers.

Kactus Biosystems Headquarter Location

4th Floor, Area 8A, No. 188 Xinjun Ring Road, Pujiang High-tech Park

Shanghai, Shanghai,

China

+86-400-614-0008

Latest Kactus Biosystems News

Orgel's Conwood project seeks additional incentives for $61M phase

Mar 3, 2021

The developers are seeking a 20-year, $19 million payment-in-lieu-of-taxes (PILOT) for the $61 million, six-story phase at 47 Keel Ave.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kactus Biosystems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kactus Biosystems is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Kactus Biosystems Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kactus Biosystems Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.